Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
5,400
Employees5,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
5,400
Employees5,400

VRTX Key Statistics

Market cap
104.75B
Market cap104.75B
Price-Earnings ratio
-202.04
Price-Earnings ratio-202.04
Dividend yield
Dividend yield
Average volume
2.62M
Average volume2.62M
High today
$409.60
High today$409.60
Low today
$403.00
Low today$403.00
Open price
$403.14
Open price$403.14
Volume
212.58K
Volume212.58K
52 Week high
$519.88
52 Week high$519.88
52 Week low
$377.85
52 Week low$377.85

VRTX News

The Motley Fool 5d
Why This Beaten-Down Growth Stock Is a No-Brainer Buy on the Dip

Every investor has heard the phrase "buy low, sell high." It's a simple enough piece of advice that's less simple to apply. What exactly qualifies as "low"? One...

Why This Beaten-Down Growth Stock Is a No-Brainer Buy on the Dip

Analyst ratings

61%

of 36 ratings
Buy
61.1%
Hold
30.6%
Sell
8.3%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.